» Articles » PMID: 21808731

Efficacy of Chronic Antidepressant Treatments in a New Model of Extreme Anxiety in Rats

Overview
Publisher Wiley
Date 2011 Aug 3
PMID 21808731
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Animal models of anxious disorders found in humans, such as panic disorder and posttraumatic stress disorder, usually include spontaneous and conditioned fear that triggers escape and avoidance behaviors. The development of a panic disorder model with a learned component should increase knowledge of mechanisms involved in anxiety disorders. In our ethological model of extreme anxiety in the rat, forced apnea was combined with cold water vaporization in an inescapable situation. Based on the reactions of vehicle controls, behaviors involved in paroxysmic fear were passive (freezing) and active (jumping) reactions. Our results show that subchronic fluoxetine (5 mg/kg, IP, 21 days) and imipramine (10 mg/kg, IP, 14 days) administration alleviated freezing and jumping behaviors, whereas acute fluoxetine (1 mg/kg, IP) provoked opposite effects. Acute low dose of diazepam (1 mg/kg, IP) was not effective, whereas the higher dose of 3 mg/kg, IP, and clonazepam (1 mg/kg, IP) only had an effect on jumping. Paroxysmic fear generated in this experimental condition may therefore mimic the symptomatology observed in patients with anxiety disorders.

Citing Articles

Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala.

Marcinkiewcz C, Mazzone C, DAgostino G, Halladay L, Hardaway J, DiBerto J Nature. 2016; 537(7618):97-101.

PMID: 27556938 PMC: 5124365. DOI: 10.1038/nature19318.


Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction.

Lebron-Milad K, Tsareva A, Ahmed N, Milad M Behav Brain Res. 2013; 253:217-22.

PMID: 23886596 PMC: 4106477. DOI: 10.1016/j.bbr.2013.07.024.

References
1.
Misslin R . The defense system of fear: behavior and neurocircuitry. Neurophysiol Clin. 2003; 33(2):55-66. DOI: 10.1016/s0987-7053(03)00009-1. View

2.
Gorman J, Goetz R, Dillon D, Liebowitz M, Fyer A, Davies S . Sodium D-lactate infusion of panic disorder patients. Neuropsychopharmacology. 1990; 3(3):181-9. View

3.
Blanchard D, Griebel G, Blanchard R . The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol. 2003; 463(1-3):97-116. DOI: 10.1016/s0014-2999(03)01276-7. View

4.
Pobbe R, Zangrossi Jr H, Blanchard D, Blanchard R . Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. Eur Neuropsychopharmacol. 2010; 21(4):306-15. PMC: 3250220. DOI: 10.1016/j.euroneuro.2010.05.004. View

5.
Bakker A, van Balkom A, van Dyck R . Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia. Int Clin Psychopharmacol. 2000; 15 Suppl 2:S25-30. DOI: 10.1097/00004850-200008002-00005. View